-
Founded in:
1987-09-10 -
Country:
China -
Address:
No. 36, Taishan Road, Shantou City -
Tax NO.:
91440500192729292G -
Registered Funds:
83.98 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefradine |
This product is a first-generation cephalosporin, which has good antibacterial effect on some strains of Gram-positive cocci such as non-penicillinase-producing and penicillinase-producing Staphylococcus aureus, coagulase-negative Staphylococci, group A hemolytic Streptococcus, Streptococcus pneumoniae and viridans Streptococcus. Anaerobic Gram-positive bacteria are mostly sensitive to this product, and Bacteroides fragilis is resistant to this product. Methicillin-resistant Staphylococci and Enterococci are resistant to this product. The effect of this product on Gram-positive and Gram-negative bacteria is similar to that of cephalexin. This product has a certain effect on Neisseria gonorrhoeae, and is also active against enzyme-producing Neisseria gonorrhoeae; its activity against Haemophilus influenzae is poor. The mechanism of action is to inhibit the synthesis of bacterial cell walls.
More
This product is a first-generation cephalosporin, which has good antibacterial effect on some strains of Gram-positive cocci such as non-penicillinase-producing and penicillinase-producing Staphylococcus aureus, coagulase-negative Staphylococci, group A hemolytic Streptococcus, Streptococcus pneumoniae and viridans Streptococcus. Anaerobic Gram-positive bacteria are mostly sensitive to this product, and Bacteroides fragilis is resistant to this product. Methicillin-resistant Staphylococci and Enterococci are resistant to this product. The effect of this product on Gram-positive and Gram-negative bacteria is similar to that of cephalexin. This product has a certain effect on Neisseria gonorrhoeae, and is also active against enzyme-producing Neisseria gonorrhoeae; its activity against Haemophilus influenzae is poor. The mechanism of action is to inhibit the synthesis of bacterial cell walls. |
38821-53-3 | 27 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Astragali Radix |
|
0 | ||
| SAPOSHNIKOVIAE RADIX |
|
0 | ||
| Atractylodes macrocephala (fried) |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lisinopril Dihydrate |
This product is a third-generation angiotensin converting enzyme inhibitor, which can inhibit the activity of angiotensin converting enzyme, reduce the concentration of angiotensin II and aldosterone, increase plasma renin activity, lead to peripheral vasodilation and decreased vascular resistance, and thus produce a hypotensive effect. The hypotensive effect occurs within about 2 hours after oral administration, and the maximum hypotensive effect occurs about 4 to 6 hours after oral administration, which is consistent with the peak time of blood drug concentration (tmax). The hypotensive effect lasts for 24 hours, and there will be no blood pressure rebound after stopping the drug, and there is no significant change in heart rate after taking the drug.
More
This product is a third-generation angiotensin converting enzyme inhibitor, which can inhibit the activity of angiotensin converting enzyme, reduce the concentration of angiotensin II and aldosterone, increase plasma renin activity, lead to peripheral vasodilation and decreased vascular resistance, and thus produce a hypotensive effect. The hypotensive effect occurs within about 2 hours after oral administration, and the maximum hypotensive effect occurs about 4 to 6 hours after oral administration, which is consistent with the peak time of blood drug concentration (tmax). The hypotensive effect lasts for 24 hours, and there will be no blood pressure rebound after stopping the drug, and there is no significant change in heart rate after taking the drug. |
83915-83-7 | 21 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Simvastatin |
This product is a methylhydroxyglutaryl coenzyme A (HMG-COA) reductase inhibitor, which inhibits the synthesis of endogenous cholesterol and is a blood lipid regulator. It has the effect of reducing the cholesterol (TC) content in the serum, liver, and aorta of hyperlipidemia rabbits, and reducing the levels of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C).
More
This product is a methylhydroxyglutaryl coenzyme A (HMG-COA) reductase inhibitor, which inhibits the synthesis of endogenous cholesterol and is a blood lipid regulator. It has the effect of reducing the cholesterol (TC) content in the serum, liver, and aorta of hyperlipidemia rabbits, and reducing the levels of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C). |
79902-63-9 | 63 |